NIH Grants Exclusive License for Enhanced Cancer-Fighting T Cells
Published Date: 12/23/2025
Notice
Summary
The National Institutes of Health plans to give EnZeta Immunotherapies an exclusive license to use a new way of boosting T cells to fight tumors better. This means EnZeta can develop and sell special T cell treatments for solid tumors and related conditions worldwide. If you want to comment or apply for a license, you have until January 7, 2026, so act fast!
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in